Teladoc Health, Inc. (NYSE:TDOC) Insider Carlos Nueno Sells 3,958 Shares

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the sale, the insider now owns 17,645 shares of the company's stock, valued at $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Teladoc Health Stock Up 5.1%

TDOC traded up $0.35 on Friday, reaching $7.28. 5,275,426 shares of the company traded hands, compared to its average volume of 6,288,824. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -1.26 and a beta of 1.82. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The stock's 50 day moving average price is $7.15 and its 200-day moving average price is $9.13.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth $29,000. Golden State Wealth Management LLC boosted its stake in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares during the period. National Bank of Canada FI increased its holdings in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,581 shares during the period. Lindbrook Capital LLC boosted its position in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Finally, SVB Wealth LLC purchased a new stake in Teladoc Health during the first quarter valued at $37,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Canaccord Genuity Group decreased their price target on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Truist Financial dropped their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a report on Tuesday, May 27th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Citigroup reduced their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research report on Friday, April 25th. Finally, Stifel Nicolaus lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and a consensus target price of $9.60.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.